# A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions

> **NCT06266988** · PHASE1 · UNKNOWN · sponsor: **Viatris Inc.** · enrollment: 48 (estimated)

## Conditions studied

- Chronic Heart Failure

## Interventions

- **DRUG:** Sacubitril and Valsartan Tablets 97mg/103mg
- **DRUG:** Entresto (Sacubitril and Valsartan Tablets 97mg/103mg)

## Key facts

- **NCT ID:** NCT06266988
- **Lead sponsor:** Viatris Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-03
- **Primary completion:** 2024-04
- **Final completion:** 2024-08
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2024-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06266988

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06266988, "A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06266988. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*